Request a Rep Visit

Indication
Natroba^TM Topical Suspension is a scabicide indicated for the topical treatment of scabies infestations in adult and pediatric patients four (4) years of age and older.

Adjunctive Measures

Wash in hot water or dry-clean any bedding, clothing and towels used by anyone having scabies.
If any member of a household presents with scabies, all household members should be treated with Natroba^™ Topical Suspension.

Important Safety Information
Natroba^™ Topical Suspension contains benzyl alcohol and is not recommended for use in pediatric patients below the age of 4 years. The safety and effectiveness of Natroba^™ Topical Suspension have not been established in pediatric patients less than 4 years of age with scabies infestation. Most common adverse events were: application site irritation (3%)* and dry skin (2%).

*Application site irritation also includes application site pain and burning sensation.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Important Safety Information

Indication
Natroba^TM Topical Suspension is a scabicide indicated for the topical treatment of scabies infestations in adult and pediatric patients four (4) years of age and older.

Adjunctive Measures

Wash in hot water or dry-clean any bedding, clothing and towels used by anyone having scabies.
If any member of a household presents with scabies, all household members should be treated with Natroba^™ Topical Suspension.

Important Safety Information
Natroba^™ Topical Suspension contains benzyl alcohol and is not recommended for use in pediatric patients below the age of 4 years. The safety and effectiveness of Natroba^™ Topical Suspension have not been established in pediatric patients less than 4 years of age with scabies infestation. Most common adverse events were: application site irritation (3%)* and dry skin (2%).

*Application site irritation also includes application site pain and burning sensation.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Privacy Policy
Terms of Use
Contact